Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,430.00
+3.00 (0.06%)
Aug 15, 2025, 3:30 PM JST

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 36.41B JPY in the quarter ending June 30, 2025, a decrease of -0.65%. This brings the company's revenue in the last twelve months to 161.48B, down -6.64% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.

Revenue (ttm)
161.48B
Revenue Growth
-6.64%
P/S Ratio
2.50
Revenue / Employee
44.67M
Employees
3,615
Market Cap
403.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024165.60B-7.86B-4.53%
Dec 31, 2023173.46B7.20B4.33%
Dec 31, 2022166.26B11.01B7.09%
Dec 31, 2021155.25B4.74B3.15%
Dec 31, 2020150.51B-17.54B-10.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Japan Tobacco 3,314.41B
Seven & i Holdings 10.37T
Ajinomoto Co. 1,529.06B
Pan Pacific International Holdings 2,215.91B
Kao Corporation 1,649.48B
Asahi Group Holdings 2,920.01B
Unicharm 965.42B
Kirin Holdings Company 2,378.87B
Revenue Rankings